Mini-hyper-CVD with low-dose inotuzumab ozogamicin is an effective induction strategy for adults with immunomodulatory drug-associated B-cell acute lymphoblastic leukemia

Leukemia Research · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles